A PHASE 2, 16-WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS SAFETY, TOLERABILITY AND EFFICACY OF REPEATED DOSES OF KB001-A IN SUBJECTS INFECTED WITH P. AERUGINOSA

被引：0

作者：

Chmiel, J. ^{[1
]}

Hamblett, N. M. ^{[2
]}

Geller, D. ^{[3
]}

Konstan, M. ^{[1
]}

VanDevanter, D. ^{[1
]}

Thompson, V ^{[2
]}

Molfino, N. ^{[3
]}

Yarranton, G. ^{[3
]}

Shreeniwas, R. ^{[3
]}

机构：

[1] Case Western Reserve Univ, Cleveland, OH 44106 USA

[2] Seattle Childrens Hosp, Seattle, WA USA

[3] KaloBios Pharmaceut Inc, San Francisco, CA USA

来源：

PEDIATRIC PULMONOLOGY | 2015年 / 50卷

关键词：

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

218

引用

页码：272 / 272

页数：1

共 50 条

[31] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RESPONSE STUDY TO ASSESS EFFICACY AND SAFETY OF PALIPERIDONE PALMITATE IN ADULT SUBJECTS WITH SCHIZOPHRENIA
Pandina, Gahan
Lindenmayer, J.
Lull, J.
Lim, P.
Gassmann-Mayer, C.
Yuen, E.
Palumbo, J.
Gopal, S.
SCHIZOPHRENIA BULLETIN, 2009, 35 : 370 - 370
[32] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF GEVOKIZUMAB IN THE TREATMENT OF GIANT CELL ARTERITIS
Dasgupta, Bhaskar
RHEUMATOLOGY, 2014, 53 : 7 - 7
[33] Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects
Venkateshwarlu Kudiganti
Raveendra Ramamurthy Kodur
Sushma Raveendra Kodur
Manjunath Halemane
Dheeraj Kumar Deep
Lipids in Health and Disease, 15
[34] Efficacy and tolerability of Meratrim for weight management: a randomized, double-blind, placebo-controlled study in healthy overweight human subjects
Kudiganti, Venkateshwarlu
Kodur, Raveendra Ramamurthy
Kodur, Sushma Raveendra
Halemane, Manjunath
Deep, Dheeraj Kumar
LIPIDS IN HEALTH AND DISEASE, 2016, 15
[35] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
Kopecky, E.
O'Connor, M.
Varanasi, R.
Saim, S.
Fleming, A.
JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
[36] Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial
Lisa M. Pitchford
Patricia M. Driver
John C. Fuller
Wendell S. Akers
Naji N. Abumrad
Venkataraman Amarnath
Ginger L. Milne
Sheau-Chiann Chen
Fei Ye
L. Jackson Roberts
M. Benjamin Shoemaker
John A. Oates
John A. Rathmacher
Olivier Boutaud
BMC Pharmacology and Toxicology, 21
[37] Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial
Pitchford, Lisa M.
Driver, Patricia M.
Fuller, John C., Jr.
Akers, Wendell S.
Abumrad, Naji N.
Amarnath, Venkataraman
Milne, Ginger L.
Chen, Sheau-Chiann
Ye, Fei
Roberts, L. Jackson, II
Shoemaker, M. Benjamin
Oates, John A.
Rathmacher, John A.
Boutaud, Olivier
BMC PHARMACOLOGY & TOXICOLOGY, 2020, 21 (01):
[38] Efficacy and Tolerability of Cyproheptadine in Poor Appetite: A Multicenter, Randomized, Double-blind, Placebo-controlled Study
Kim, Sue Youn
Yun, Jae Moon
Lee, Ji-Won
Cho, Young Gyu
Cho, Kyung-Hwan
Park, Yong Gyu
Cho, Belong
CLINICAL THERAPEUTICS, 2021, 43 (10) : 1757 - +
[39] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Targan, Stephan R.
Feagan, Brian G.
Vermeire, Severine
Panaccione, Remo
Melmed, Gil Y.
Blosch, Consuelo
Newmark, Richard
Zhang, Nan
Chon, Yun
Lin, Shao-Lee
Klekotka, Paul
GASTROENTEROLOGY, 2012, 143 (03) : E26 - E26
[40] Safety and tolerability of KarXT (xanomeline-trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia
Correll, Christoph U.
Angelov, Angel S.
Miller, Andrew C.
Weiden, Peter J.
Brannan, Stephen K.
SCHIZOPHRENIA, 2022, 8 (01)

← 1 2 3 4 5 →